Von Hippel-Lindau disease: Ocular manifestations, surveillance, systemic associations, and emerging molecular therapies.

Kopinski PK, Duffner SJ, Anguita R.

Open source

DOI
10.1016/j.beem.2026.102162
Published
2026-08-20
Container
Best Pract Res Clin Endocrinol Metab
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.beem.2026.102162,
  title = {Von Hippel-Lindau disease: Ocular manifestations, surveillance, systemic associations, and emerging molecular therapies.},
  author = {Kopinski PK and  Duffner SJ and  Anguita R.},
  year = {2026},
  journal = {Best Pract Res Clin Endocrinol Metab},
  doi = {10.1016/j.beem.2026.102162},
  url = {https://doi.org/10.1016/j.beem.2026.102162}
}

RIS

TY  - JOUR
TI  - Von Hippel-Lindau disease: Ocular manifestations, surveillance, systemic associations, and emerging molecular therapies.
AU  - Kopinski PK
AU  -  Duffner SJ
AU  -  Anguita R.
PY  - 2026
JO  - Best Pract Res Clin Endocrinol Metab
DO  - 10.1016/j.beem.2026.102162
UR  - https://doi.org/10.1016/j.beem.2026.102162
ER  - 

APA

PK, K., SJ, D., & R., A. (2026). Von Hippel-Lindau disease: Ocular manifestations, surveillance, systemic associations, and emerging molecular therapies.. Best Pract Res Clin Endocrinol Metab. https://doi.org/10.1016/j.beem.2026.102162

Source records